IP Library Granted Patent US 8,076,496
Granted Patent B2
US 8,076,496 · App. 13/043,274 · Granted Dec 13, 2011

Chemoselective ligation

Assignee: The Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,076,496
App. No.
13/043,274
Granted
Dec 13, 2011
Kind
B2
Abstract

The present invention features a chemoselective ligation reaction that can be carried out under physiological conditions. In general, the invention involves condensation of a specifically engineered phosphine, which can provide for formation of an amide bond between the two reactive partners resulting in a final product comprising a phosphine moiety, or which can be engineered to comprise a cleavable linker so that a substituent of the phosphine is transferred to the azide, releasing an oxidized phosphine byproduct and producing a native amide bond in the final product. The selectivity of the reaction and its compatibility with aqueous environments provides for its application in vivo (e.g., on the cell surface or intracellularly) and in vitro (e.g., synthesis of peptides and other polymers, production of modified (e.g., labeled) amino acids).

Claims (22)

1. A compound having the formula:

wherein n is an integer from 1 to 6, and R 1 , R 2 , R 3 and R 4 are each independently hydrogen or acetyl.

2. The compound of claim 1 having the formula:

3. The compound of claim 2 having the formula:

4. The compound of claim 3 having the formula:

5. The compound of claim 4 , wherein R 1 , R 2 , R 3 and R 4 are each acetyl.

6. The compound of claim 5 , wherein n is 1.

7. The compound of claim 3 having the formula:

8. The compound of claim 7 , wherein R 1 , R 2 , R 3 and R 4 are each acetyl.

9. The compound of claim 8 , wherein n is 1.

10. The compound of claim 1 having the formula:

11. The compound of claim 10 having the formula:

12. The compound of claim 11 , wherein R 1 , R 2 , R 3 and R 4 are each acetyl.

13. The compound of claim 12 , wherein n is 1.

14. The compound of claim 1 selected from the group consisting of:

15. A method of expressing a glycoprotein comprising an azide group on the surface of a host cell comprising the steps of:

(a) contacting a host cell with compound having the structure:

wherein n is an integer from 1 to 6, and R 1 , R 2 , R 3 and R 4 are each independently hydrogen or acetyl; and

(b) allowing the host cell to express the glycoprotein on its cell surface.

16. The method of claim 15 , wherein the compound has the structure:

17. The method of claim 15 , wherein the compound has the structure:

18. The method of claim 15 , wherein the compound has the structure:

Assignments (2)
CONFIRMATORY LICENSE Recorded Dec 15, 2011
From: UNIVERSITY OF CALIFORNIA BERKELEY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027390/0803 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 27, 2011
From: SAXON, ELIANA; BERTOZZI, CAROLYN
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 026660/0280 →
Continuity (5)
Continuation 11039478 · Jan 19, 2005
Division 10384099 · Mar 6, 2003
Division 09810864 · Mar 16, 2001
Provisional Application 60189837 · Mar 16, 2000
Related Publication 20110236930A1 · Sep 29, 2011